40.99
price down icon0.68%   -0.28
after-market Dopo l'orario di chiusura: 40.99
loading

Qiagen Nv Borsa (QGEN) Ultime notizie

pulisher
Nov 18, 2024

Natixis Advisors LLC Has $35.41 Million Stock Holdings in Qiagen (NYSE:QGEN) - MarketBeat

Nov 18, 2024
pulisher
Nov 16, 2024

180,729 Shares in Qiagen (NYSE:QGEN) Purchased by Impax Asset Management Group plc - MarketBeat

Nov 16, 2024
pulisher
Nov 13, 2024

QGEN Collaborates With McGill University Centre: Stock to Gain? - Yahoo Finance Australia

Nov 13, 2024
pulisher
Nov 13, 2024

Victory Capital Management Inc. Has $117.33 Million Stock Position in Qiagen (NYSE:QGEN) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

What is William Blair's Estimate for Qiagen FY2024 Earnings? - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Crossmark Global Holdings Inc. Sells 12,133 Shares of Qiagen (NYSE:QGEN) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Pharmahungary Group participates in ambitious EU EVEREST Project - European Biotechnology News

Nov 13, 2024
pulisher
Nov 12, 2024

QIAGEN collaborates with McGill University to advance microbiome research - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

QIAGEN Partners with McGill to Target $1.8B Microbiome Market in Major Research Deal | QGEN Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

Don't Overlook Qiagen (QGEN) International Revenue Trends While Assessing the Stock - Yahoo Finance

Nov 11, 2024
pulisher
Nov 11, 2024

QIAGEN NV : UBS reiterates its Neutral rating - Marketscreener.com

Nov 11, 2024
pulisher
Nov 09, 2024

Earnings call: QIAGEN tops Q3 expectations, raises 2024 EPS outlook - Investing.com India

Nov 09, 2024
pulisher
Nov 08, 2024

Earnings call: QIAGEN tops Q3 expectations, raises 2024 EPS outlook By Investing.com - Investing.com Australia

Nov 08, 2024
pulisher
Nov 08, 2024

Qiagen Non-GAAP EPS of $0.46 beats by $0.02, revenue of $459M beats by $2.09M - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

Wellington Management Group LLP's Strategic Acquisition of Qiage - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Why Qiagen (QGEN) is a Top Value Stock for the Long-Term - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Qiagen NV (QGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - GuruFocus.com

Nov 08, 2024
pulisher
Nov 07, 2024

Qiagen Reports Strong Q3 2024 Growth - TipRanks

Nov 07, 2024
pulisher
Nov 07, 2024

QIAGEN Stock Flat Post Q3 Earnings & Revenue Beat, 2024 EPS View Up - Barchart

Nov 07, 2024
pulisher
Nov 07, 2024

Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 31% Undervaluation? - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

QIAGEN NV : Deutsche Bank reaffirms its Buy rating - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qiagen Q3 24 Earnings Conference Call At 9:30 AM ET - Nasdaq

Nov 07, 2024
pulisher
Nov 07, 2024

QIAGEN : Markets hailed the Q3 beat + the profitability upgrade - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

QIAGEN NV : Receives a Buy rating from Berenberg - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qiagen (NYSE:QGEN) Shares Sold by Van ECK Associates Corp - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Qiagen N : QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full year 2024 adjusted EPS outlook - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

QIAGEN NV : UBS reaffirms its Neutral rating - Marketscreener.com

Nov 07, 2024
pulisher
Nov 06, 2024

Qiagen N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024
pulisher
Nov 06, 2024

Compared to Estimates, Qiagen (QGEN) Q3 Earnings: A Look at Key Metrics - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Qiagen (QGEN) Q3 Earnings and Revenues Top Estimates - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Diagnostics firm Qiagen reports rise in third-quarter revenue - Reuters

Nov 06, 2024
pulisher
Nov 06, 2024

QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

QIAGEN Q3 Earnings Surge: Sales Hit $502M, Boosts 2024 EPS Outlook | QGEN Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Qiagen NV (QGEN) Q3 2024: Everything You Need to Know Ahead of E - GuruFocus.com

Nov 06, 2024
pulisher
Nov 05, 2024

FDA clears fourth Qiagen test in 2024 - BioWorld Online

Nov 05, 2024
pulisher
Nov 05, 2024

Qiagen NV (QGEN) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

QGEN Stock Set to Gain From FDA's Clearance of QIAstat-Dx Mini Panel - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Qiagen (QGEN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

Qiagen Receives FDA Clearance Of Qiastat-Dx Meningitis/Encephalitis Panel To Support Emergency Diagnostics - XM

Nov 04, 2024
pulisher
Oct 31, 2024

Forsta AP Fonden Sells 18,586 Shares of Qiagen (NYSE:QGEN) - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Qiagen (QGEN) Set to Announce Earnings on Wednesday - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Raymond James & Associates Trims Position in Qiagen (NYSE:QGEN) - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight - GlobeNewswire Inc.

Oct 29, 2024
pulisher
Oct 29, 2024

QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

Qiagen Receives FDA Clearance For Qiastat-Dx Mini Panel - XM

Oct 29, 2024
pulisher
Oct 28, 2024

Is QIAGEN (QGEN) a Good Investment Now? Key Factors to Note - MSN

Oct 28, 2024
pulisher
Oct 26, 2024

Insiders At Qiagen Sold US$7.0m In Stock, Alluding To Potential Weakness - Simply Wall St

Oct 26, 2024
pulisher
Oct 26, 2024

Qiagen (NYSE:QGEN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Oct 26, 2024
$153.42
price up icon 5.04%
diagnostics_research LH
$238.64
price up icon 1.46%
$130.74
price down icon 3.19%
diagnostics_research WAT
$355.47
price down icon 0.83%
diagnostics_research MTD
$1,174.56
price down icon 0.43%
$419.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):